Literature DB >> 32442338

Ubiquitous overexpression of CXCL12 confers radiation protection and enhances mobilization of hematopoietic stem and progenitor cells.

Smrithi Rajendiran1, Stephanie Smith-Berdan1, Leo Kunz2, Maurizio Risolino3, Licia Selleri3, Timm Schroeder2, E Camilla Forsberg1.   

Abstract

C-X-C motif chemokine ligand 12 (CXCL12; aka SDF1α) is a major regulator of a number of cellular systems, including hematopoiesis, where it influences hematopoietic cell trafficking, proliferation, and survival during homeostasis and upon stress and disease. A variety of constitutive, temporal, ubiquitous, and cell-specific loss-of-function models have documented the functional consequences on hematopoiesis upon deletion of Cxcl12. Here, in contrast to loss-of-function experiments, we implemented a gain-of-function approach by generating a doxycycline-inducible transgenic mouse model that enables spatial and temporal overexpression of Cxcl12. We demonstrated that ubiquitous CXCL12 overexpression led to an increase in multipotent progenitors in the bone marrow and spleen. The CXCL12+ mice displayed reduced reconstitution potential as either donors or recipients in transplantation experiments. Additionally, we discovered that Cxcl12 overexpression improved hematopoietic stem and progenitor cell mobilization into the blood, and conferred radioprotection by promoting quiescence. Thus, this new CXCL12+ mouse model provided new insights into major facets of hematopoiesis and serves as a versatile resource for studying CXCL12 function in a variety of contexts. © AlphaMed Press 2020.

Entities:  

Keywords:  CXCL12 transgenic; hematopoiesis; hematopoietic stem cells; mobilization; radiation protection

Mesh:

Substances:

Year:  2020        PMID: 32442338     DOI: 10.1002/stem.3205

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

Review 1.  CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis.

Authors:  Alessandra Rodriguez Y Baena; Bryce A Manso; E Camilla Forsberg
Journal:  Exp Hematol       Date:  2021-10-22       Impact factor: 3.249

2.  A quantitative hematopoietic stem cell reconstitution protocol: Accounting for recipient variability, tissue distribution and cell half-lives.

Authors:  Smrithi Rajendiran; Scott W Boyer; E Camilla Forsberg
Journal:  Stem Cell Res       Date:  2020-12-29       Impact factor: 1.587

3.  Chromatin accessibility maps provide evidence of multilineage gene priming in hematopoietic stem cells.

Authors:  Eric W Martin; Jana Krietsch; Roman E Reggiardo; Rebekah Sousae; Daniel H Kim; E Camilla Forsberg
Journal:  Epigenetics Chromatin       Date:  2021-01-06       Impact factor: 4.954

4.  Megakaryocyte progenitor cell function is enhanced upon aging despite the functional decline of aged hematopoietic stem cells.

Authors:  Donna M Poscablo; Atesh K Worthington; Stephanie Smith-Berdan; E Camilla Forsberg
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.294

5.  Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function.

Authors:  Irene Mariam Roy; P V Anu; Samantha Zaunz; Srinu Reddi; Aravind M Giri; Rithika Saroj Sankar; Sarah Schouteden; Joerg Huelsken; Catherine M Verfaillie; Satish Khurana
Journal:  iScience       Date:  2022-09-19

6.  Interleukin 7 receptor is required for myeloid cell homeostasis and reconstitution by hematopoietic stem cells.

Authors:  Taylor Cool; Atesh Worthington; Donna Poscablo; Adeel Hussaini; E Camilla Forsberg
Journal:  Exp Hematol       Date:  2020-09-08       Impact factor: 3.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.